The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>Tobias Dreyer, Holger Bronger|Cancer Immunology Research|2021Cited by 23